Board of Directors
Acarix’s board of directors is the highest decision-making body after the general meeting of shareholders.
Philip Siberg
Chairman of the Board
Year of Entry: 2021
Born: 1973
Location: Sweden
Education: MSc in mechanical engineering and industrial economy from KTH Royal Institute of Technology, Stockholm, Sweden.
Previous engagements/experience: Philip Siberg has 20 years of experience as international CEO and Board member of public and unlisted companies in medical technology and life science. Philip has previously served as an external Chief Executive Officer of Coala Life AB and as Chairman of the Board of Annexin Pharmaceuticals AB.
Other significant ongoing assignments: Chief Strategy Officer, Coala Life AB. Partner at Southbloom AB. Chairman of the Board of Senzime AB (publ) and RNB Retail Development AB. Chief Executive Officer of Longmeadow Farm AB
Acarix holdings:
400,000 Shares
500,000 Warrants
Ulf Rosén
Board Member
Year of Entry: 2014
Born: 1960
Location: Sweden
Education: Ulf Rosén is a Registered Nurse and has a degree in Business Administration from IHM Business School. He has also completed a number of traineeships, such as in executive financial management at INSEAD.
Previous engagements/experience: Ulf Rosén has been Chairman of the Board, a Board member and CEO of several Scandinavian companies in the medical technology, pharma and service sectors. Previous positions include CEO of NeoPharma AB, CEO of Attana AB, Chairman of the Board of Trial Form Support International, Stille AB and Scibase AB, General Manager of Fresenius-Kabi AB, Executive Vice President of the Global Nutrition Division at Fresenius-Kabi, CEO of Pharmacia & Upjohn AS, CEO of Globen Ögonklinik AB and General Partner in Fond III at investment company SEED Capital. Ulf is co-founder of Lobsor Pharmaceuticals AB and Intrance Holding/Intrance Medical Systems Inc.
Other significant ongoing assignments: Chairman of the Board of Intrance Holding AB, Intrance Medical Systems Inc, LobSor Holding AB, Ponscasa Holding AB and Palaggan AB.
Acarix holdings:
6,062,148 Shares
500,000 Warrants
Fredrik Buch
Board Member
Year of entry: 2021
Born: 1954
Location: Sweden
Education: MD, specializing in orthopedics with a degree from the University of Gothenburg, Sweden.
Previous engagements/experience: Fredrik Buch has worked on clinical trials and regulatory issues in the pharmaceutical and regulatory issues in the pharmaceutical industry, both in Europe and internationally, at Squibb/Bristol Meyers, Hoechst and Pharmacia/Upjohn. Since then, he has been a fund manager at SEB Läkemedelsfonder and invested worldwide in pharmaceuticals and medical technology. Forbes Magazine named the fund under Fredrik Buch as one of the 50 best funds in the world. Fredrik Buch later became a partner at HealthCap and worked on venture capital investments in life science. Over the last 15 years, Fredrik has worked as a corporate board member and consultant.
Other significant ongoing assignments: Multiple Board positions in life science companies.
Acarix holdings:
1,162,527 Shares
500,000 Warrants
Marlou Janssen-Counotte
Board Member
Year of Entry: 2020
Born: 1965
Location: Netherlands
Education: Hotel Management at TIO.
Previous engagements/experience: Marlou Janssen-Counotte has more than 25 years of experience from the MedTech industry. She began her MedTech career at Medtronic and, in the past 20 years, has held senior executive roles as Vice President at St. Jude Medical, Vice President International Marketing & Sales at Biotronik and President and Board member at Biotronik Inc.
Other significant ongoing assignments: Head of EDP Solutions at Philips Medical Systems.
Acarix holdings:
500,000 Warrants
Mikael Thoren
Board Member
Year of entry: 2023
Born: 1964
Location: Sweden
Education: BS in Development Engineering from University College, Halmstad, Sweden
Previous engagements/experience: Mikael Thoren has over twenty years of leadership experience, ranging from small Swedish companies to large multinational companies, in strategy, sales, business development, process and organizational management, and marketing within the telecommunications industry. His career includes management of strategic collaboration partners at Ericsson and International and US-based Sales for Allgon Mobile Communications AB. Mikael has also successfully operated his own consultancy and investment business for over ten years.
Other significant ongoing assignments: None
Acarix holdings, including any related person:
31,406,382 shares